News and Press Releases
Public Opinion and Moving the Needle on Healthspan
By Eve Herold - Healthspan Action Coalition Increasing the healthspan, while science-driven, requires a whole-society effort. The many actors in the movement—science, biotech, government, patients, nonprofits and the entire healthcare delivery system, make up a vital...
Could XPRIZE Healthspan deliver the ‘holy grail’ for longevity science?
By Danny Sullivan - Longevity. Technology Dr Jamie Justice on how the $101m competition can deliver a lasting legacy to the longevity field – and it’s not about the prize money. Yesterday’s launch of XPRIZE Healthspan has kicked off a seven-year, $101 million race to...
FDA Approves First Gene-Editing Treatment for Human Illness, Sickle Cell Disease
By Rob Stein – NPR In a landmark decision, the Food and Drug Administration Friday approved the first gene-editing treatment to alleviate human illness. The FDA approved two gene therapies for anyone 12 and older suffering from the most severe form of sickle cell...
Scientists at King’s College London and bit.bio Collaborate to Develop Multi-Cell Models of the Human Brain
By Businesswire CAMBRIDGE, England--(BUSINESS WIRE)--bit.bio, the company coding human cells for novel cures, and the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London today announce a collaboration to build multi-cell models of...
Pushing Forward on Understanding Cellular Decline
By Josh Conway - Lifespan.io - Disruption to genetic structures is associated with the expression of old viral genes. Researchers publishing in Nature Aging have investigated one of the core biological reasons behind the decline of stem cells’ ability to proliferate....
A Life-Extension Drug for Big Dogs Is Getting Closer to Reality
By Emily Mullin - Wired The FDA has yet to approve any drugs for life extension. But biotech company Loyal is now a step closer to bringing one to market—for dogs. There’s a well-established inverse relationship between a dog’s size and its expected lifespan. Bernese...
Our vision statement is clear: Expand healthy lifespan for the benefit of all
By Longevity.Technology Ahead of the Global Healthspan Summit, Hevolution CEO Mehmood Khan updates on the Foundation’s progress and explains why nothing happens without talent. Whenever you convene the best minds of any field, and in this case, related to healthy...
XPRIZE on aging will award up to $101 million for therapies that restore vigor to the elderly
By Matt Fuchs - Science The XPRIZE Foundation announced on November 29th $101 million in prizes for researchers who can restore the function of an elderly person’s muscle, cognition, and immune system to a more youthful state. The competition, backed by Saudi money...
Tiny living robots made from human cells surprise scientists
By Katie Hunt, CNN Scientists have created tiny living robots from human cells that can move around in a lab dish and may one day be able to help heal wounds or damaged tissue, according to a new study. A team at Tufts University and Harvard University’s Wyss...
Video – Dublin Longevity Declaration- We can control age-related morbidity and mortality!
By Michael Mann, MHA - Video on LinkedIn Longevity Summit Dublin #34 Dublin Longevity Declaration - We can control age-related morbidity and mortality! - Planetary Health First Mars Next, Bernard Siegel, Bill Remak Bernard Siegel writes: I thought this short clip was...
Improving heart health habits may slow biological aging
By Regina Schaffer - Healio PHILADELPHIA — Data presented at the American Heart Association Scientific Sessions show that higher overall CV health as measured by the Life’s Essential 8 score is associated with lower biological age. Phenotypic age, a new...
Dr. Desiree Cox has received a prestigious award in The Bahamas!
NASSAU, The Bahamas – Prime Minister and Minister of Finance the Hon. Philip Davis noted, on November 27, 2023, that the Golden Jubilee Independence Award of Supreme Honour was an award with a “grand title to reflect the grand achievements” of its recipients. Our own...